News & Press Releases
Israel 21C News– Test your glucose level without drawing blood
February 14th, 2017
We are proud to be illustrate in the Israel21C.org news on 2nd Feb, 2017. http://www.israel21c.org/test-your-glucose-level-without-drawing-blood Israeli maker of GlucoTrack believes its noninvasive meter will encourage people with Type 2 diabetes to check glucose levels more often. By Abigail Klein Leichman FEBRUARY 2, 2017, 4:20 PM GlucoTrack DF-F, Integrity Applications’ noninvasive glucose meter using an ear […]
Read MoreGlucoTrack® Maker Appoints New Chief Financial Officer
February 6th, 2017
GlucoTrack® Maker Appoints New Chief Financial Officer Ashdod, Israel, February 6, 2017 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today the appointment of Sami Sassoun as chief financial officer (CFO) effective February 1st, 2017. Mr. Sassoun […]
Read More DownloadGlucoTrack® maker to Present at the 9th Annual LD Micro Investor Conference on December 8th in Los Angeles
December 7th, 2016
GlucoTrack® maker to Present at the 9th Annual LD Micro Investor Conference on December 8th in Los Angeles LOS ANGELES, CA / ACCESSWIRE / December 5th, 2016 / Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that Angela Strand, […]
Read MoreGlucoTrack® Maker Names Two New Board Members
November 13th, 2016
GlucoTrack® Maker Names Two New Board Members Philip M. Darivoff, Former Goldman Sachs Partner, and Revan R. Schwartz Esq., Former General Counsel of Andrew Garrett, appointed effective November 9th, 2016 ASHDOD, Israel, Nov. 11, 2016 /PRNewswire/ Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type […]
Read More DownloadGlucoTrack® Maker to Present Updated Scientific Data Demonstrating Increased Accuracy
November 11th, 2016
GlucoTrack® Maker to Present Updated Scientific Data Demonstrating Increased Accuracy Presentation includes information from recently concluded German and Israeli Trials ASHDOD, Israel, Nov. 10, 2016 /PRNewswire/ Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it is presenting today […]
Read More DownloadGlucoTrack® Maker Announces Receipt of Final Regulatory Approval in South Korea
November 7th, 2016
GlucoTrack® Maker Announces Receipt of Final Regulatory Approval in South Korea Receives immediate first order from distributor ASHDOD, Israel, Nov. 7, 2016 /PRNewswire/ Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it has received the final regulatory […]
Read More DownloadGlucoTrack® Maker Submitted Pre-Submission Supplement to US FDA
June 1st, 2016
GlucoTrack® Maker Submitted Pre-Submission Supplement to US FDA SHDOD, Israel, June 1, 2016 /PRNewswire/ – Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes, announced that it has set a conference call with the United States Food and Drug Administration (FDA), expected to […]
Read More DownloadGlucoTrack® maker to Present at Marcum and LD Micro Investor Conferences on June 2nd in New York City and June 7th in Los Angeles
June 1st, 2016
GlucoTrack® maker to Present at Marcum and LD Micro Investor Conferences on June 2nd in New York City and June 7th in Los Angeles ASHDOD, Israel, May 31, 2016 /PRNewswire/ – Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a noninvasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced […]
Read More DownloadGlucoTrack® Maker Names Two New Board Members
March 24th, 2016
Ashdod, Israel, March 23, 2016 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced today that it appointed Angela Strand and Leslie Seff to its Board of Directors, effective March 23, 2016. Ms. Strand will also chair the […]
Read More DownloadGlucoTrack® Maker Receives New EU Certification
February 20th, 2016
Annex II Certification Enables Faster Sales On Modified Products ASHDOD, Israel, Feb. 19, 2016 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, today announced that it has received an extension of its ISO 13485:2003 certificate and Annex II […]
Read MoreGlucoTrack® Maker Hires Chief Operating Officer
January 13th, 2016
GlucoTrack® Maker Hires Chief Operating Officer Ashdod, Israel, January 12, 2016 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it has hired Eran Cohen as its Chief Operating Officer (COO). Mr. Cohen brings over 17 years of […]
Read More DownloadGlucoTrack® Hires International Sales and Business Development Manager Will Assist in Building Global Sales Network
December 11th, 2015
GlucoTrack® Hires International Sales and Business Development Manager Will Assist in Building Global Sales Network Ashkelon, Israel, December 10, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk of developing diabetes, announced today that it has hired […]
Read More DownloadGlucoTrack® Maker CEO Chairs and Presents at Annual World Congress of Diabetes – 2015
December 1st, 2015
GlucoTrack® Maker CEO Chairs and Presents at Annual World Congress of Diabetes – 2015 Gal Invited to Chair Session on Medical Devices in Diabetes Ashkelon, Israel, November 30, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk […]
Read More DownloadGlucoTrack® Moves Forward with FDA Approval Process
October 30th, 2015
GlucoTrack® Moves Forward with FDA Approval Process Clinical Trial Initiation Planned for Early 2016 Ashkelon, Israel, October 29, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk of developing diabetes, announced today that on October 19, 2015, it […]
Read MoreGlucoTrack® Maker Holds First International Distributor Conference
October 26th, 2015
GlucoTrack® Maker Holds First International Distributor Conference Conference Promotes Sale Readiness in Europe ASHKELON, Israel, October 26, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk of developing diabetes, announced that it held its first Distributors Conference in […]
Read More DownloadIntegrity Applications Receives CE Mark Approval for Multiple Improvements to GlucoTrack® Model DF-F
August 31st, 2015
Integrity Applications Receives CE Mark Approval for Multiple Improvements to GlucoTrack® Model DF-F ASHKELON, Israel, August 31, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), has announced that it has received CE Mark approval from Dekra Certification B.V., its Notified Body in the European Union for improvements to the GlucoTrack model DF-F noninvasive glucose measurement […]
Read More DownloadIntegrity Applications Submits protocol to FDA (August 13 2015)
August 13th, 2015
Integrity Applications Submits Pre-Submission Documents for the GlucoTrack Model DF-F to U.S. FDA ASHKELON, Israel, August 13, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive glucose measurement device, has announced that on August 10th, 2015 it submitted pre-submission documents to the U.S. Food and Drug Administration (the “FDA”) […]
Read More DownloadIntegrity Applications Names Prof. Lutz Heinemann to Advisory Board
February 27th, 2015
Integrity Applications Names Prof. Lutz Heinemann to Advisory Board Preeminent Expert In Diabetes Study Will Head New Advisory Board ASHKELON, Israel, February 26, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F, a noninvasive device that tracks blood glucose levels, announced today that Dr. […]
Read MoreIntegrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China
February 19th, 2015
Integrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China Noninvasive Blood Glucose Measurement Device For Diabetes ASHKELON, Israel, February 17, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, […]
Read MoreIntegrity Applications, Inc. Announces Completion of Successful $8.5 Million Equity Financing
January 5th, 2015
Integrity Applications, Inc. Announces Completion of Successful $8.5 Million Equity Financing ASHKELON, Israel, January 5, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that, on December 31, 2014, it raised an aggregate of $1,647,450 through the sale […]
Read More
